Mimura, Kazuya published the artcileAtypical preeclampsia without underlying disease and elevated sFlt-1/ PlGF ratio, HPLC of Formula: 21829-25-4, the publication is Journal of Obstetrics and Gynaecology Research (2022), 48(2), 471-476, database is CAplus and MEDLINE.
Atypical preeclampsia before 20 wk of gestation without an underlying disease is very rare; however, the soluble Fms-like tyrosine kinase 1/placental growth factor (sFlt-1/PlGF) ratios remain unknown. Four pregnant women with no underlying disease, except for a history of childhood IgA vasculitis, developed preeclampsia at 13, 14, 17, and 18 wk of gestation with sFlt-1/PlGF ratios of 1589, 1183, 500, and 1460 pg/mL, resp. Their pregnancies were terminated, and they delivered within 2 wk. All previously abnormal clin. findings normalized within 3 mo. The sFlt-1/PlGF ratios were elevated in the four patients with atypical preeclampsia without underlying disease before 20 wk of gestation. A high sFlt-1/PlGF ratio may be indicative of preeclampsia when no underlying disease is present in pregnancies of less than 20 wk of gestation.
Journal of Obstetrics and Gynaecology Research published new progress about 21829-25-4. 21829-25-4 belongs to pyridine-derivatives, auxiliary class Membrane Transporter/Ion Channel,Calcium Channel, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, HPLC of Formula: 21829-25-4.
Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem